Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Albert Labs International Corp. (ABRT.CN)

Albert Labs International Corp. (ABRT.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 372
  • Shares Outstanding, K 74,413
  • Annual Sales, $ 0 K
  • Annual Income, $ -7,059 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta -1.36
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
  • Price/Earnings ttm N/A
  • Earnings Per Share ttm -0.05
  • Most Recent Earnings $0.00 on 11/29/23
  • Next Earnings Date N/A
  • Annual Dividend & Yield (Fwd) N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector N/A
  • INDUSTRY GROUPING:

    SIC-2834 Pharmaceutical Preparations

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.0050 unch
on 07/19/24
0.0350 -85.71%
on 06/20/24
-0.0050 (-50.00%)
since 06/19/24
3-Month
0.0050 unch
on 07/19/24
0.0350 -85.71%
on 06/20/24
-0.0150 (-75.00%)
since 04/19/24
52-Week
0.0050 unch
on 07/19/24
0.0350 -85.71%
on 06/20/24
-0.0200 (-80.00%)
since 07/19/23

Most Recent Stories

More News
Albert Labs Receives preliminary acceptance of 35 Novel Inventive Claims for Patent Protected Manufacturing Technology

Albert Labs has received preliminary acceptance of 35 novel inventive claims as part of its published International PCT Patent Application (No....

ABRT.CN : 0.0050 (unch)
Albert Labs announces Private Placement

Albert Labs has announced a private placement for gross proceeds of up to CAD $3,000,000, with the first tranche offered at CAD $0.08/Unit 80% of the Company's...

ABRT.CN : 0.0050 (unch)
Albert Labs announces Strategic Investment from Cantheon Capital LLC for First In-Human Trials

Highlights: Cantheon Capital, one of the largest global pharmaceutical psychedelics venture capital firms, sign terms for ~CA$830,000 (£500,000) of funding to...

ABRT.CN : 0.0050 (unch)
COF : 200.34 (-3.90%)
Albert Labs Validates Global Supply Chain for Controlled Substances

/CNW/ - Albert Labs International Corp. (CSE: ABRT) (FSE: VB50), the "Company" or "Albert Labs"), a fully-integrated biopharmaceutical company bringing...

ABRT.CN : 0.0050 (unch)
Albert Labs signs Letter of Intent (LOI) with iNGENū CRO for First In-Human Clinical Studies

/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focused on gaining...

ABRT.CN : 0.0050 (unch)
Albert Labs provides Corporate Update

/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focussed on gaining...

ABRT.CN : 0.0050 (unch)
Albert Labs Files New International PCT Patent Application for scalable API manufacturing

/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focussed on gaining...

ABRT.CN : 0.0050 (unch)
Albert Labs Appoints Two Industry Leading Directors

/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), a pharmaceutical drug development company focussed on gaining...

ABRT.CN : 0.0050 (unch)
Albert Labs Appoints Principal Investigator for Real World Evidence Study for KRN-101

/CNW/ - Albert Labs International Corp. (Albert Labs (CSE: ABRT) (FSE: VB50), the "Company"), an R&D company developing mental health therapeutic medicines, is...

ABRT.CN : 0.0050 (unch)
Albert Labs Granted Health Canada Licence

/CNW/ - Albert Labs International Corp. (CSE: ABRT) (FSE: VB50) (the "Company"), a research and drug development company using advanced culture technology to...

ABRT.CN : 0.0050 (unch)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Albert Labs International Corp is a laboratory-based, clinical research, and drug development enterprise addressing mental health care needs. The company is focusing on Real World Evidence (RWE) the company will initially look to commercialize its mycelium-based KRN-101 medicine and treatment with the...

See More

Key Turning Points

3rd Resistance Point 0.0050
2nd Resistance Point 0.0050
1st Resistance Point 0.0050
Last Price 0.0050
1st Support Level 0.0050
2nd Support Level 0.0050
3rd Support Level 0.0050

See More

52-Week High 0.0350
Fibonacci 61.8% 0.0235
Fibonacci 50% 0.0200
Fibonacci 38.2% 0.0165
Last Price 0.0050
52-Week Low 0.0050

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar